Wave Pharma (WVE): Rasio rega marang bathi tumrap wutah
High clinical trial expenses for RNA drugs are creating financial pressure for Wave Life Sciences (WVE), yet the company's current PEG valuation demonstrates investment potential. The value of 0.00 determines the current magnitude of this metric. These concerns are mitigated by the PRISM AI platform for developing sterile therapies, as well as a strategic alliance with Takeda and GSK, which accelerates product commercialization and optimizes business margins.
Wave Life Sciences (WVE) - rincian metrik lan laporan keuangan
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- statistik nilai buku emiten:
- statistik kawajiban utang lan likuiditas:
Utang marang Modal Wave Life Sciences|WVE - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal wavelifesciences.com|WVE - Utang perusahaan|Utang-utang marang aset resik Wave Life Sciences Corp|WVE - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Wave Life Sciences|Koefisien jangkoan perantara wavelifesciences.com
- data bathi resik lan rasio valuasi:
WVE - Bathi resik|Bathi resik sing dikarepake Wave Life Sciences|WVE - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep Wave Pharma|WVE - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Wave Life Sciences Corp|WVE - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Wave Life Sciences|WVE - Bathi saben saham sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan wavelifesciences.com|WVE - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Wave Life Sciences
Analisis fundamental perusahaan:WVE, Wave Life Sciences Ltd
The PEG ratio determines the fairness of an asset's market value by comparing the current P/E multiple with the growth rate of earnings per share. Analyzing the price-to-earnings-to-EPS growth ratio reveals the undervaluation of Wave Life Sciences (WVE), where the robotization of oligonucleotide synthesis and the automation of RNA chain screening should ensure an exponential acceleration of business development, justifying the company's investment attractiveness.
Perusahaan pesaing
TEM (Tempus AI, Inc) - Koefisien bali modal nimbang wutah|Rasio rega marang bathi tumrap wutah Qiagen Group QGEN|Isis Pharmaceuticals - Rasio rega marang bathi tumrap wutah|Repligen Corporation - Pangali PEG|Kapitalisasi marang bathi resik kanthi nimbang wutah aviditybiosciences.com RNA|CRSP: Pangali PEG|Rasio kapitalisasi marang bathi lan wutah WGS (GeneDx Holdings)|RARE (Ultragenyx Pharma) - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Beam Tx BEAM|Pangali rega marang bathi tumrap wutah SRPT (Sarepta Therapeutics, Inc.)|TWST (twistbioscience.com) - Koefisien bali modal nimbang wutah|Rasio rega marang bathi tumrap wutah 10x Genomics TXG|Kapitalisasi marang bathi resik kanthi nimbang wutah Intellia Therapeutics Inc (NTLA)|Stoke - Pangali PEG|BioLife (BLFS) - Pangali rega marang bathi tumrap wutah|MAZE: Pangali PEG|SION - Kapitalisasi marang bathi resik kanthi nimbang wutah|PRME (Prime Medicine) - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Taysha Gene Therapies Inc TSHA|Rasio rega marang bathi tumrap wutah uniQure Corp (QURE)|MeiraGTx Corp - Rasio P/E diaturake wutah|Pangali PEG RGNX (REGENXBIO Inc.)|SLDB - Pangali rega marang bathi tumrap wutah|Ocugen - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Pacific Biosciences of California, Inc.|Benitec (BNTC) - Rasio rega marang bathi tumrap wutah|DSGN - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali rega marang bathi tumrap wutah RCKT|Pangali rega marang bathi tumrap wutah 4dmoleculartherapeutics.com (FDMT)|Pangali rega marang bathi tumrap wutah LXEO (Lexeo Therapeutics)|Rasio rega marang bathi tumrap wutah KRRO (korrobio.com)|Pangali PEG EDIT (Editas)|Silence Therapeutics Corp (SLN) - Rega marang bathi kanthi panyesuaian wutah|ProQR Therapeutics NV - Pangali PEG|CDXS (Codexis, Inc.) - Rasio P/E diaturake wutah|Sangamo Therapeutics, Inc. (SGMO) - Rasio rega marang bathi tumrap wutah|Rasio P/E diaturake wutah NAUT|MGX (Metagenomi, Inc) - Pangali PEG|Pangali PEG Precision BioSciences Inc.|Pangali rega marang bathi tumrap wutah GBIO (Generation Bio Co.)|Pangali rega marang bathi tumrap wutah boundlessbio.com BOLD|Pangali PEG XCUR (Exicure)|Pangali PEG Imunon Inc IMNN|PHIO: Pangali rega marang bathi tumrap wutah|MBIO: Rasio rega marang bathi tumrap wutah|RNAZ: Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Bionano Genomics (BNGO)|Pangali rega marang bathi tumrap wutah APDN|BLUE: Koefisien bali modal nimbang wutah|Rasio rega marang bathi tumrap wutah ImmunoPrecise Antibodies (IPA)|Rasio rega marang bathi tumrap wutah OMGA (Omega Therapeutics Corp)|Pangali PEG OMIC (Singular Genomics Systems)|Kapitalisasi marang bathi resik kanthi nimbang wutah regulusrx.com (RGLS)|Syros Pharmaceuticals, Inc. - Pangali PEG|Rasio kapitalisasi marang bathi lan wutah TBIO|TCON: Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Unity Biotechnology, Inc (UBX)
